Lotus Pharmaceutical Co., Ltd. (TPE:1795)

Lotus Pharmaceutical Revenue

Lotus Pharmaceutical had revenue of 8.81B TWD in the quarter ending June 30, 2026, with 85.56% growth. This brings the company's total for the last twelve months to 28.49B, up 48.98% year-over-year. In the year 2025, Lotus Pharmaceutical had annual revenue of 20.51B with 10.36% growth. That makes Lotus Pharmaceutical the 8,246th largest company in the world by revenue and 211th in Taiwan.

• Revenue (ttm): 28.49B
• Revenue Growth: +48.98%
• P/S Ratio: 1.66
• Revenue / Employee: 25.92M
• Employees: 1,099
• Market Cap: 47.73B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceuticals Segment 20.35B 98.0%
• Other Segment 420.30M 2.0%

By Geography

Chart

• United States 8.73B 42.6%
• South Korea 5.80B 28.3%
• Others 3.41B 16.6%
• Taiwan 2.57B 12.5%

Fiscal year ended Dec 31, 2025 See the full Lotus Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	20.51B	1.93B	10.36%
Dec 31, 2024	18.58B	1.63B	9.59%
Dec 31, 2023	16.96B	2.33B	15.89%
Dec 31, 2022	14.63B	1.98B	15.68%
Dec 31, 2021	12.65B	1.92B	17.90%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error